- STRP +151% on being acquired by AT&T.
- CYTX +34% on receiving U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract.
- GERN +21% on announcing completion of second internal data reviews for Imetelstat trials being conducted by Janssen.
- AXON +19% on announcing appointment of Dr. David Hung as CEO and Expansion of Board of Directors.
- SWFT +19% on announcing guidance for 1Q17.
- GSAT +15%
- CETX +15% on receiving Multi-million Dollar Order From New Customer.
- AKRX +12%.
- SMIT +12%.
- XCRA +10% on being acquired for approx.$580M by Unic Capital Management Co., Ltd, an Affiliate of Sino IC Capital.
- XGTI +7%.